Patent Number: 6,617,329

Title: Aminoquinazolines and their use as medicaments

Abstract: Compounds of the formula ##STR1## having an inhibitory effect on signal transduction mediated by tyrosine kinases, their use in the treatment of diseases, especially tumoral diseases and diseases of the lungs and air-ways, and the preparation thereof.

Inventors: Himmelsbach; Frank (Mittelbiberach, DE), Langkopf; Elke (Warthausen, DE), Jung; Birgit (Schwabenheim, DE), Blech; Stefan (Warthausen, DE), Solca; Flavio (Wien, AT)

Assignee: Boehringer Ingelheim Pharma KG

International Classification: A61K 31/517 (20060101); A61K 31/505 (20060101); C07D 413/00 (20060101); C07D 413/14 (20060101); C07D 405/14 (20060101); C07D 498/00 (20060101); C07D 405/12 (20060101); C07D 405/00 (20060101); C07D 413/12 (20060101); C07D 498/04 (20060101); C07D 239/94 (); C07D 405/12 (); C07D 413/12 (); A61K 031/517 (); A61P 035/00 ()

Expiration Date: 09/09/2020